{"id":42574,"date":"2025-09-30T16:40:41","date_gmt":"2025-09-30T08:40:41","guid":{"rendered":"https:\/\/flcube.com\/?p=42574"},"modified":"2025-09-30T16:40:42","modified_gmt":"2025-09-30T08:40:42","slug":"astrazeneca-announces-dual%e2%80%91market-direct-listing-on-nyse-harmonising-global-share-structure","status":"publish","type":"post","link":"https:\/\/flcube.com\/?p=42574","title":{"rendered":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure"},"content":{"rendered":"\n<p><strong>AstraZeneca plc (AZ; <a href=\"https:\/\/www.google.com\/finance\/quote\/AZN:NASDAQ\">NASDAQ: AZN<\/a>)<\/strong> has unveiled a plan to standardise its share\u2011listing structure across the <strong>London Stock Exchange (LSE)<\/strong>, <strong>Nasdaq Stockholm (STO)<\/strong> and the <strong>New\u202fYork Stock Exchange (NYSE)<\/strong>. The move will replace the company\u2019s current U.S. listing of <strong>American Depositary Receipts (ADRs)<\/strong> on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for <strong>February\u202f2,\u202f2026<\/strong>.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-key-points-of-the-transition\">Key Points of the Transition<\/h2>\n\n\n\n<ul class=\"wp-block-list\">\n<li><strong>Direct NYSE Listing<\/strong> \u2013 AstraZeneca will issue ordinary shares directly on the NYSE, aligning all U.S. equity exposure with its European listings.<\/li>\n\n\n\n<li><strong>Retention of London Listing<\/strong> \u2013 Despite rumours in July of a U.K.\u2011to\u2011U.S. listing shift, the company confirms it will maintain its headquarters in the United Kingdom and keep its primary listing on the LSE.<\/li>\n\n\n\n<li><strong>Shareholder Vote<\/strong> \u2013 The proposal to finalise the three\u2011market structure will be put to a shareholder vote on <strong>November\u202f3,\u202f2025<\/strong>.<\/li>\n<\/ul>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-strategic-rationale\">Strategic Rationale<\/h2>\n\n\n\n<p>AstraZeneca\u2019s decision to unify its share structure aims to reduce regulatory complexity, improve liquidity, and provide a clearer, single\u2011price point for global investors. The direct NYSE listing is expected to simplify cross\u2011border trading and enhance price discovery for the company\u2019s equity, while preserving its strong presence in the U.K. and European markets.<\/p>\n\n\n\n<h2 class=\"wp-block-heading\" id=\"h-market-implications\">Market Implications<\/h2>\n\n\n\n<p>Analysts anticipate that the streamlined listing will attract a broader base of institutional investors and could modestly lift the company\u2019s market capitalisation by easing access to U.S. capital. The consolidation also positions AstraZeneca to better compete with peers that have already harmonised their global equity footprints.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across&#8230;<\/p>\n","protected":false},"author":1,"featured_media":42575,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAownpewDA:productID":"","_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[7,10],"tags":[130,72,871],"class_list":["post-42574","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-company","category-deals","tag-astrazeneca","tag-ipo","tag-nasdaq-azn"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v27.5) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure - Insight, China&#039;s Pharmaceutical Industry<\/title>\n<meta name=\"description\" content=\"AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across the London Stock Exchange (LSE), Nasdaq Stockholm (STO) and the New\u202fYork Stock Exchange (NYSE). The move will replace the company\u2019s current U.S. listing of American Depositary Receipts (ADRs) on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for February\u202f2,\u202f2026.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/flcube.com\/?p=42574\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure\" \/>\n<meta property=\"og:description\" content=\"AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across the London Stock Exchange (LSE), Nasdaq Stockholm (STO) and the New\u202fYork Stock Exchange (NYSE). The move will replace the company\u2019s current U.S. listing of American Depositary Receipts (ADRs) on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for February\u202f2,\u202f2026.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/flcube.com\/?p=42574\" \/>\n<meta property=\"og:site_name\" content=\"Insight, China&#039;s Pharmaceutical Industry\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/profile.php?id=61566606313834\" \/>\n<meta property=\"article:published_time\" content=\"2025-09-30T08:40:41+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-09-30T08:40:42+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1080\" \/>\n\t<meta property=\"og:image:height\" content=\"608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Fineline Cube\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:description\" content=\"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Fineline Cube\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574\"},\"author\":{\"name\":\"Fineline Cube\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\"},\"headline\":\"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure\",\"datePublished\":\"2025-09-30T08:40:41+00:00\",\"dateModified\":\"2025-09-30T08:40:42+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574\"},\"wordCount\":266,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3012.webp\",\"keywords\":[\"AstraZeneca\",\"IPO\",\"NASDAQ: AZN\"],\"articleSection\":[\"Company\",\"Deals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42574#respond\"]}],\"copyrightYear\":\"2025\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574\",\"url\":\"https:\\\/\\\/flcube.com\\\/?p=42574\",\"name\":\"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure - Insight, China&#039;s Pharmaceutical Industry\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3012.webp\",\"datePublished\":\"2025-09-30T08:40:41+00:00\",\"dateModified\":\"2025-09-30T08:40:42+00:00\",\"description\":\"AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across the London Stock Exchange (LSE), Nasdaq Stockholm (STO) and the New\u202fYork Stock Exchange (NYSE). The move will replace the company\u2019s current U.S. listing of American Depositary Receipts (ADRs) on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for February\u202f2,\u202f2026.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/flcube.com\\\/?p=42574\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#primaryimage\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3012.webp\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2025\\\/09\\\/3012.webp\",\"width\":1080,\"height\":608,\"caption\":\"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/flcube.com\\\/?p=42574#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/flcube.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#website\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"name\":\"Insight, China's Pharmaceutical Industry\",\"description\":\"Fineline Insights, Pharma Clarity\",\"publisher\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/flcube.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#organization\",\"name\":\"Fineline Infomation and Technology\",\"alternateName\":\"Fineline Info & Tech\",\"url\":\"https:\\\/\\\/flcube.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/flcube.com\\\/wp-content\\\/uploads\\\/2024\\\/11\\\/Fineline-info-tech-scaled.jpg\",\"width\":2560,\"height\":1894,\"caption\":\"Fineline Infomation and Technology\"},\"image\":{\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/profile.php?id=61566606313834\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/flcube.com\\\/#\\\/schema\\\/person\\\/19ad11870d326204db8524d3c3c5e66a\",\"name\":\"Fineline Cube\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g\",\"caption\":\"Fineline Cube\"},\"sameAs\":[\"https:\\\/\\\/flcube.com\"],\"url\":\"https:\\\/\\\/flcube.com\\\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure - Insight, China&#039;s Pharmaceutical Industry","description":"AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across the London Stock Exchange (LSE), Nasdaq Stockholm (STO) and the New\u202fYork Stock Exchange (NYSE). The move will replace the company\u2019s current U.S. listing of American Depositary Receipts (ADRs) on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for February\u202f2,\u202f2026.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/flcube.com\/?p=42574","og_locale":"en_US","og_type":"article","og_title":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure","og_description":"AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across the London Stock Exchange (LSE), Nasdaq Stockholm (STO) and the New\u202fYork Stock Exchange (NYSE). The move will replace the company\u2019s current U.S. listing of American Depositary Receipts (ADRs) on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for February\u202f2,\u202f2026.","og_url":"https:\/\/flcube.com\/?p=42574","og_site_name":"Insight, China&#039;s Pharmaceutical Industry","article_publisher":"https:\/\/www.facebook.com\/profile.php?id=61566606313834","article_published_time":"2025-09-30T08:40:41+00:00","article_modified_time":"2025-09-30T08:40:42+00:00","og_image":[{"width":1080,"height":608,"url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp","type":"image\/png"}],"author":"Fineline Cube","twitter_card":"summary_large_image","twitter_description":"Navigate the complexities of China\u2019s pharmaceutical industry with precision and clarity. FLCUBE delivers reliable data, news, and intelligence to broaden your horizons and sharpen your decision-making. Stay informed, stay ahead with FLCUBE.COM","twitter_misc":{"Written by":"Fineline Cube","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/flcube.com\/?p=42574#article","isPartOf":{"@id":"https:\/\/flcube.com\/?p=42574"},"author":{"name":"Fineline Cube","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a"},"headline":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure","datePublished":"2025-09-30T08:40:41+00:00","dateModified":"2025-09-30T08:40:42+00:00","mainEntityOfPage":{"@id":"https:\/\/flcube.com\/?p=42574"},"wordCount":266,"commentCount":0,"publisher":{"@id":"https:\/\/flcube.com\/#organization"},"image":{"@id":"https:\/\/flcube.com\/?p=42574#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp","keywords":["AstraZeneca","IPO","NASDAQ: AZN"],"articleSection":["Company","Deals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/flcube.com\/?p=42574#respond"]}],"copyrightYear":"2025","copyrightHolder":{"@id":"https:\/\/flcube.com\/#organization"}},{"@type":"WebPage","@id":"https:\/\/flcube.com\/?p=42574","url":"https:\/\/flcube.com\/?p=42574","name":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure - Insight, China&#039;s Pharmaceutical Industry","isPartOf":{"@id":"https:\/\/flcube.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/flcube.com\/?p=42574#primaryimage"},"image":{"@id":"https:\/\/flcube.com\/?p=42574#primaryimage"},"thumbnailUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp","datePublished":"2025-09-30T08:40:41+00:00","dateModified":"2025-09-30T08:40:42+00:00","description":"AstraZeneca plc (AZ; NASDAQ: AZN) has unveiled a plan to standardise its share\u2011listing structure across the London Stock Exchange (LSE), Nasdaq Stockholm (STO) and the New\u202fYork Stock Exchange (NYSE). The move will replace the company\u2019s current U.S. listing of American Depositary Receipts (ADRs) on Nasdaq with a direct listing of ordinary shares on the NYSE, scheduled for February\u202f2,\u202f2026.","breadcrumb":{"@id":"https:\/\/flcube.com\/?p=42574#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/flcube.com\/?p=42574"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/?p=42574#primaryimage","url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp","width":1080,"height":608,"caption":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure"},{"@type":"BreadcrumbList","@id":"https:\/\/flcube.com\/?p=42574#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/flcube.com\/"},{"@type":"ListItem","position":2,"name":"AstraZeneca Announces Dual\u2011Market Direct Listing on NYSE, Harmonising Global Share Structure"}]},{"@type":"WebSite","@id":"https:\/\/flcube.com\/#website","url":"https:\/\/flcube.com\/","name":"Insight, China's Pharmaceutical Industry","description":"Fineline Insights, Pharma Clarity","publisher":{"@id":"https:\/\/flcube.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/flcube.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/flcube.com\/#organization","name":"Fineline Infomation and Technology","alternateName":"Fineline Info & Tech","url":"https:\/\/flcube.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/","url":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","contentUrl":"https:\/\/flcube.com\/wp-content\/uploads\/2024\/11\/Fineline-info-tech-scaled.jpg","width":2560,"height":1894,"caption":"Fineline Infomation and Technology"},"image":{"@id":"https:\/\/flcube.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/profile.php?id=61566606313834"]},{"@type":"Person","@id":"https:\/\/flcube.com\/#\/schema\/person\/19ad11870d326204db8524d3c3c5e66a","name":"Fineline Cube","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/89f733aaed3d2d91d7d6f45d0e9ab509e3004e8243c6e57620b36380684657f2?s=96&d=mm&r=g","caption":"Fineline Cube"},"sameAs":["https:\/\/flcube.com"],"url":"https:\/\/flcube.com\/?author=1"}]}},"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/flcube.com\/wp-content\/uploads\/2025\/09\/3012.webp","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42574","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=42574"}],"version-history":[{"count":1,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42574\/revisions"}],"predecessor-version":[{"id":42576,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/posts\/42574\/revisions\/42576"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=\/wp\/v2\/media\/42575"}],"wp:attachment":[{"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=42574"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=42574"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/flcube.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=42574"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}